— Know what they know.
Not Investment Advice

NNLX OTC

NanoLogix, Inc.
1W: +0.0% 1M: +0.0% 3M: -20.0% YTD: -20.0% 1Y: -20.0% 3Y: -20.0% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $9569 mcap · 46M float · 0.0011% daily turnover · Short 62% of daily vol

Income Trends

Revenue
$36K -59.7% ▼
5Y CAGR: +7.3%
Gross Profit
-$710K +17.3% ▲
Operating Income
-$1M +26.4% ▲
Net Income
-$1M +26.0% ▲
EPS (Diluted)
$-0.01 +29.2% ▲
EBITDA
-$1M +26.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2009FY2010FY2011FY2012FY2013
Revenue$21K$640$892$88K$36K
YoY Growth-14.6%-97.0%+39.4%+9802.9%-59.7%
Cost of Revenue$0$0$928K$947K$746K
Gross Profit$0$0-$927K-$858K-$710K
Gross Margin0.0%0.0%-103944.8%-971.8%-1994.6%
R&D Expenses$127K$449K$491K$333K$165K
SG&A Expenses$918K$2M$442K$570K$421K
Operating Expenses$1M$3M$933K$905K$588K
Operating Income-$1M-$3M-$2M-$2M-$1M
Operating Margin-5024.4%-413620.9%-208531.2%-1995.9%-3646.2%
Interest Expense$380$808$781$773$2K
Income Before Tax-$1M-$3M-$2M-$2M-$1M
Tax Expense$0$0$0$0$0
Net Income-$1M-$3M-$2M-$2M-$1M
Net Margin-5430.8%-414966.3%-208618.7%-1977.3%-3631.2%
EPS (Diluted)$-0.01$-0.02$-0.02$-0.01$-0.01
EBITDA-$1M-$3M-$2M-$2M-$1M
Shares Outstanding104M111M115M122M127M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms